These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10745610)

  • 1. Vasoseal hemostasis following coronary interventions with abciximab.
    Lunney L; Karim K; Little T
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():2B-3B. PubMed ID: 10745610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoseal hemostasis following coronary interventions with Abciximab.
    Lunney L; Karim K; Little T
    Cathet Cardiovasc Diagn; 1998 Aug; 44(4):405-6. PubMed ID: 9716204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times.
    Silber S; Björvik A; Mühling H; Rösch A
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():19B-24B. PubMed ID: 10745613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen application for sealing of arterial puncture sites in comparison to pressure dressing: a randomized trial.
    Schräder R; Steinbacher S; Burger W; Kadel C; Vallbracht C; Kaltenbach M
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():14B-18B. PubMed ID: 10745612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett).
    Michalis LK; Rees MR; Patsouras D; Katsouras CS; Goudevenos J; Pappas S; Sourla E; Kolettis T; Sioros L; Zotou P; Gartzou-Matsouka P; Sideris DA
    Cardiovasc Intervent Radiol; 2002; 25(5):423-9. PubMed ID: 12132030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access.
    Choussat R; Black A; Bossi I; Fajadet J; Marco J
    Eur Heart J; 2000 Apr; 21(8):662-7. PubMed ID: 10731404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving femoral artery hemostasis after cardiac catheterization: a comparison of methods.
    Schickel SI; Adkisson P; Miracle V; Cronin SN
    Am J Crit Care; 1999 Nov; 8(6):406-9. PubMed ID: 10553181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinski EJ; Roubin GS
    J Am Coll Cardiol; 1993 Nov; 22(5):1273-9. PubMed ID: 8227779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the StarClose device for obtaining femoral artery hemostasis.
    Rodriguez A; Katz SG
    Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
    Assali AR; Sdringola S; Moustapha A; Ghani M; Salloum J; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):1-5. PubMed ID: 12508187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
    Siudak Z; Zawislak B; Dziewierz A; Rakowski T; Jakala J; Bartus S; Noworolnik B; Zasada W; Dubiel JS; Dudek D
    Coron Artery Dis; 2010 Aug; 21(5):292-7. PubMed ID: 20453640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
    Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
    Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing bedrest following arterial puncture for coronary interventional procedures--impact on vascular complications: the BAC Trial.
    Vlasic W; Almond D; Massel D
    J Invasive Cardiol; 2001 Dec; 13(12):788-92. PubMed ID: 11731689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures.
    Nader RG; Garcia JC; Drushal K; Pesek T
    J Invasive Cardiol; 2002 Jun; 14(6):305-7. PubMed ID: 12042620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of cardiac catheterization in the current era: a single-center experience.
    Chandrasekar B; Doucet S; Bilodeau L; Crepeau J; deGuise P; Gregoire J; Gallo R; Cote G; Bonan R; Joyal M; Gosselin G; Tanguay JF; Dyrda I; Bois M; Pasternac A
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):289-95. PubMed ID: 11246238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
    Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
    Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.